The teratogenicity of cyclophosphamide (endoxan-asta) in rats
Singh, S.
Indian Journal of Medical Research 59(7): 1128-1135
1971
ISSN/ISBN: 0019-5340 PMID: 5170660 Document Number: 41131
Document emailed within 1 workday
Related Documents
Singh, S.; Tuli, S.M.; Gupta, P.K. 1971: Skeletal defects induced by cyclophosphamide (endoxan-asta) in chick embryos--preliminary report Acta Orthopaedica Scandinavica 42(3): 217-226Dold, U.W.; Gaertner, H.J. 1972: Pharmacokinetic behavior of cyclophosphamide (Endoxan) in the human organism Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 169-172
Kumar, S.; Raghunath, P.N.; Joseph, C.D.; Vasudevan, D.M. 1985: Studies with MPG against the side effects of cyclophosphamide (Endoxan)--a preliminary study Indian Journal of Cancer 22(3): 228-232
Mietkiewski, K.; Karoń, H.; Warchol, J.B.; Król, C. 1973: Effect of cyclophosphamide (endoxan) on histochemical reactions in the liver. I. Histoenzymatic studies Patologia Polska 24(1): 145-155
Ujházy, E.; Balonová, T.; Durisová, M.; Gajdosík, A.; Jansák, J.; Molnárová, A. 1993: Teratogenicity of cyclophosphamide in New Zealand white rabbits Neoplasma 40(1): 45-49
Lauria, F.; Baccarani, M.; Fiacchini, M.; Frezza, R.; Gobbi, M.; Tura, S. 1978: 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas Cancer Treatment Reports 62(8): 1193-1197
Foerster, H.; Lierse, W. 1975: Vulnerability of early postnatal differention processes of the retina and the teratogenic effect of cyclophosphamide (Endoxan) Acta Anatomica 93(2): 161-170
Beijnen, J.H.; van Gijn, R.; Challa, E.E.; Kaijser, G.P.; Underberg, W.J. 1992: Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(4): 111-116
Weinstein, D.; Ornoy, A.; Ben-Zur, Z.; Pfeifer, Y.; Sulman, G.H. 1975: Teratogenicity of cyproheptadine in pregnant rats Archives Internationales de Pharmacodynamie et de Therapie 215(2): 345-349
Aho, K.; Huttunen, J. 1979: Should ASTA be prohibited by law? Duodecim; Laaketieteellinen Aikakauskirja 95(17): 1056-1058
Montz, F.J.; Wolff, A.J.; Gambone, J.C. 1991: Gonadal protection and fecundity rates in cyclophosphamide-treated rats Cancer Research 51(8): 2124-2126
Kumar, S.; Gupta, R.K.; Bhake, A.S.; Samal, N. 1992: Cardiotoxic effects of high doses of cyclophosphamide in albino rats Archives Internationales de Pharmacodynamie et de Therapie 319: 58-65
Visnovský, P. 1992: The effect of cyclophosphamide and methotrexate on gastric emptying and secretion in rats Bratislavske Lekarske Listy 93(2): 90-92
Iskander, K.G.; Abusinna, I.M. 1988: Effect of cyclophosphamide, fluorouracil and their combination on dental caries in rats Egyptian Dental Journal 34(3): 273-285
Paterson, P.Y.; Drobish, D.G. 1975: Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats Clinical and Experimental Immunology 20(1): 125-129
Harrison, E.F.; Fuquay, M.E.; Hunter, H.L. 1983: Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats Seminars in Oncology 10(1 Suppl 1: 25-28
Husberg, B.S.; Ericsson, H. 1978: Influence of cyclophosphamide on the antibody response evoked by an experimental sarcoma in rats Transplantation 26(2): 135-137
Buczko, W.; Popow, J. 1976: Influence of trypsin on cytostatic effects of cyclophosphamide in rats with Guerin tumours Acta Physiologica Polonica 27(4): 387-394
Leprán, I.; Koltai, M.; Szekeres, L. 1981: Effect of cyclophosphamide on the acute phase of experimental myocardial infarction in rats Acta Physiologica Academiae Scientiarum Hungaricae 58(4): 311-315
Juszczak, K.; Królczyk, G.; Filipek, M.; Dobrowolski, Z.F.; Thor, P.J. 2007: Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats Folia Medica Cracoviensia 48(1-4): 113-123